Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160.
Ann Rheum Dis
; 71(10): 1671-9, 2012 Oct.
Article
en En
| MEDLINE
| ID: mdl-22459542
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Artritis Reumatoide
/
Factor de Necrosis Tumoral alfa
/
Antirreumáticos
/
Anticuerpos Monoclonales
Tipo de estudio:
Clinical_trials
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2012
Tipo del documento:
Article